AURA
Price
$6.28
Change
-$0.01 (-0.16%)
Updated
Jun 27 closing price
Capitalization
389.39M
39 days until earnings call
VACBF
Price
$0.20
Change
-$0.03 (-13.04%)
Updated
Jun 3 closing price
Capitalization
60.91M
Interact to see
Advertisement

AURA vs VACBF

Header iconAURA vs VACBF Comparison
Open Charts AURA vs VACBFBanner chart's image
Aura Biosciences
Price$6.28
Change-$0.01 (-0.16%)
Volume$1.31M
Capitalization389.39M
NYKODE THERAPEUTICS AS
Price$0.20
Change-$0.03 (-13.04%)
Volume$200
Capitalization60.91M
AURA vs VACBF Comparison Chart in %
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. VACBF commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and VACBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (AURA: $6.28 vs. VACBF: $0.20)
Brand notoriety: AURA and VACBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 557% vs. VACBF: 8%
Market capitalization -- AURA: $389.39M vs. VACBF: $60.91M
AURA [@Biotechnology] is valued at $389.39M. VACBF’s [@Biotechnology] market capitalization is $60.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileVACBF’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • VACBF’s FA Score: 1 green, 4 red.
According to our system of comparison, AURA is a better buy in the long-term than VACBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 3 TA indicator(s) are bullish while VACBF’s TA Score has 2 bullish TA indicator(s).

  • AURA’s TA Score: 3 bullish, 4 bearish.
  • VACBF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, VACBF is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а +3.97% price change this week, while VACBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

AURA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($389M) has a higher market cap than VACBF($60.9M). VACBF YTD gains are higher at: -15.033 vs. AURA (-23.601). VACBF has higher annual earnings (EBITDA): -30.2M vs. AURA (-101.63M). AURA has more cash in the bank: 128M vs. VACBF (106M). VACBF has less debt than AURA: VACBF (3.28M) vs AURA (18.4M). VACBF has higher revenues than AURA: VACBF (7.85M) vs AURA (0).
AURAVACBFAURA / VACBF
Capitalization389M60.9M639%
EBITDA-101.63M-30.2M337%
Gain YTD-23.601-15.033157%
P/E RatioN/AN/A-
Revenue07.85M-
Total Cash128M106M121%
Total Debt18.4M3.28M561%
TECHNICAL ANALYSIS
Technical Analysis
AURAVACBF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
13%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
17%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
21%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
12%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLOQ0.140.01
+7.69%
Cyberloq Technologies Inc.
CRYCY3.09N/A
N/A
China Railroad Signal & Communication Corp Ltd.
SLTCY4.50N/A
N/A
Siltronic AG
HMENF1.35-0.02
-1.47%
Hemisphere Energy Corp.
NETTF25.11-3.01
-10.70%
NetEase, Inc.

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-0.16%
MGTX - AURA
53%
Loosely correlated
-0.90%
VRDN - AURA
51%
Loosely correlated
-1.37%
IDYA - AURA
51%
Loosely correlated
-4.13%
BEAM - AURA
50%
Loosely correlated
-1.98%
CCCC - AURA
48%
Loosely correlated
-7.89%
More

VACBF and

Correlation & Price change

A.I.dvisor tells us that VACBF and EYEN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VACBF and EYEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VACBF
1D Price
Change %
VACBF100%
N/A
EYEN - VACBF
27%
Poorly correlated
+39.99%
SPHRY - VACBF
26%
Poorly correlated
N/A
REVB - VACBF
26%
Poorly correlated
-7.44%
VTYX - VACBF
25%
Poorly correlated
-4.29%
AURA - VACBF
22%
Poorly correlated
-0.16%
More